New research identifies potential protective agent against flu
A new study by researchers at the University of Maryland School of Medicine has identified an innovative strategy for treating influenza, and perhaps other infectious diseases as well. Scientists showed that a small protein called retrocyclin-101 (RC-101) could potentially improve the symptoms and mortality associated with the flu and possibly other types of infectious illness as well.
The protein is unique in that it not only targets the flu virus itself, but also the harmful inflammation the virus triggers in the host.
While the effect of RC-101 has been studied as a flu treatment in cells before, it has never been studied in animals. The research appears in the most recent issue of the Journal of Leukocyte Biology.
“Every year, thousands of people across the country die from the flu or its complications — despite widespread use of annual influenza vaccines,” said the study’s lead author, Daniel J. Prantner, a research associate in the Department of Microbiology and Immunology at the University of Maryland School of Medicine (UM SOM). “We think that this protein could lead to medicines that could be a powerful tool in the battle against this disease, and against inflammation in general.”
For this study, Dr. Prantner and his colleagues studied the effects of RC-101 on human cells, and in an animal model of flu, using mice. The researchers studied human immune cells, and found that RC-101 had two positive effects. First, it blocked the flu virus from infecting the cells; second it blocked the runway inflammation that is behind most symptoms of influenza infection, such as fever, pain, lethargy, and trouble breathing. This double action is unique, Dr. Prantner says.
In the animal model, the researchers infected two groups of mice with a dose of influenza that is typically lethal. They gave one of these groups RC-101 two days after infection for a total of five days, and gave the other group a placebo. The mice that were treated with RC-101 exhibited less severe symptoms of the flu and also decreased rates of death. Among the control group, 90 percent of the mice died; among the group that was given RC-101, only 20 percent died.
Although RC-101 does not exist in humans, it does exist in some other animals, including orangutans, and provides powerful antiviral protection. It appears to have been lost over the course of recent primate evolution. Chimpanzees and gorillas, for example, do not have it.
One of the study’s principal investigators, Alfredo Garzino-Demo, PhD, an associate professor in the UM SOM Department of Microbiology and Immunology and at the UM SOM Institute of Human Virology, is planning research to see whether the protein can be effective against Dengue, Zika, and other viral infections that can cause damage via inflammation.
The Latest on: Influenza
via Google News
The Latest on: Influenza
- France reports high pathogenic avian influenza caseon November 29, 2021 at 12:39 am
A poultry farm in the north of France was hit with an outbreak of highly pathogenic avian influenza this weekend.
- Guest Opinion | Doctor is In: Get the influenza and COVID-19 vaccineon November 28, 2021 at 7:20 pm
For nearly two years, the COVID-19 pandemic has been at the center of everyone’s lives. With COVID-19 taking up most of the spotlight, it can be easy to forget that the flu season is upon us.
- Increasing seasonal influenza A (H3N2) activity: CDC health advisoryon November 28, 2021 at 12:25 pm
The Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) Health Advisory about increased influenza A(H3N2) activity that could mark the beginning of the 2021-2022 ...
- Croatia reports H5N1 avian influenza caseon November 28, 2021 at 6:19 am
Croatia has reported an outbreak of the highly pathogenic H5N1 avian influenza virus in backyard poultry. According to the World Organisation for Animal Health (OIE), the outbreak occurred in the ...
- Epidemiology of influenzaon November 26, 2021 at 6:11 pm
The epidemiological pattern of influenza over the past century is outlined; its vagaries are ascribed to the plasticity of the influenza virus. In recent years it has been possible to carry out ...
- How our genetic ancestry shapes our immune response to influenzaon November 26, 2021 at 2:55 am
A study has revealed how ancestry and associated genetic variation can explain population-level differences in the immune response to the influenza virus.
- Study finds relationship between immune pathway response to influenza and genetic ancestryon November 25, 2021 at 11:00 am
New research at the University of Chicago has found differences in immune pathway activation to influenza infection between individuals of European and African genetic ancestry. Many of the genes that ...
- San Diegans Urged to Get Vaccinated Against Influenzaon November 24, 2021 at 10:30 am
Influenza cases in the San Diego region have been steadily increasing, prompting County health officials to encourage residents to continue getting vaccinated.
- Low pathogenic avian influenza found in Kandiyohi County turkey flock, birds can overcome the mild illnesson November 23, 2021 at 1:05 pm
A commercial turkey flock in Kandiyohi County has tested positive for H5 low pathogenic avian influenza. This is not the same highly pathogenic virus that circulated among area flocks in 2015. The ...
- Seqirus Announces U.S. FDA Approval for Multi-Dose Vial Presentation of First-Ever Adjuvanted, Cell-Based Pandemic Influenza Vaccineon November 23, 2021 at 5:37 am
The FDA has granted approval of multi-dose vial presentation for AUDENZ™ to help protect individuals six months of age and older against influenza A(H5N1) in the event of a pandemic.1 As the ...
via Bing News